Sign in

HSTM on Nasdaq

HEALTHSTREAM INC

HEALTHSTREAM INC is an American computer programming, data processing services company.2 It is headquartered in Nashville, United States.2 Its shares trade on Nasdaq under the symbol HSTM.2

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Health Catalyst, Inc., Eventbrite or PubMatic, Inc., or pick any stock.

  • TickerHSTM on Nasdaq2
  • IndustryServices-Computer Programming, Data Processing, Etc.2
  • HeadquartersNashville, United States2
  • Incorporated inTN3
  • Business address500 11Th Avenue North, Suite 850, Nashville, Tn3
  • Filer categoryAccelerated filer3
  • Legal formCorporation2
  • LEI529900OJ88H8635JNH642
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address209 10th Avenue, South, Suite 450, 37203 Nashville, United States2
  • Registered withBusiness Services (Department of State), 0002330532

See how the biggest companies compare on our leaderboards

HealthStream’s focus is and has always been on improving the quality of healthcare through the development and support of the dedicated individuals who deliver care. Like healthcare itself, our mission remains constant, but how we accomplish that mission continues to evolve and improve over time. Originally, we pioneered the use of online learning to hospitals, which began with courses specifically tailored to educate healthcare professionals and meet hospitals' required regulatory needs, and we remain a leading innovator in those areas today. Since our inception, the scope of HealthStream’s Software-as-a-Service (SaaS) solutions has expanded well beyond our governance, risk, and compliance (GRC) offerings to include a diverse ecosystem of applications that optimize and support the healthcare workforce and the students preparing to enter that workforce. Today, we are characterized by our…5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

6.7%Operating margin6
6.0%Net margin6
4.3%Revenue growth, 20256
5.2%Return on equity6
$59.6MFree cash flow6

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Subscription Services brought in 97% of the revenue HEALTHSTREAM INC broke down this way in fiscal 2025.

  1. Subscription Services$293.6M697%up 5% from 2024
  2. Professional Services$10.4M63%down 8% from 2024
Products and services by year
Products and services202320242025
Subscription Services$267.9M$280.3M$293.6M
Professional Services$11.1M$11.3M$10.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development17¢$51.0M
  • Other costs76¢$229.9M
  • Income tax2¢$4.9M
  • Profit6¢$18.3M

Out of $304.1M in revenue.6

Where each dollar of operating cash went, fiscal 2025

  • Capital spending6¢$3.7M
  • Dividends paid6¢$3.7M
  • Share buybacks47¢$30.0M
  • Kept or used elsewhere41¢$25.9M

Out of $63.3M of cash from operations.6

Financial statements

Revenue789106$304.1M in 2025+20% since 2019
0$100.0M$200.0M$300.0M$400.0M2019: $254.1M$254.1M20192020: $244.8M$244.8M2020−4%2021: $256.7M$256.7M2021+5%2022: $266.8M$266.8M2022+4%2023: $279.1M$279.1M2023+5%2024: $291.6M$291.6M2024+5%2025: $304.1M$304.1M2025+4%
Operating income789106$20.2M in 2025+37% since 2019
0$10.0M$20.0M$30.0M2019: $14.7M$14.7M20192020: $15.8M$15.8M2020+7%2021: $8.1M$8.1M2021−49%2022: $12.4M$12.4M2022+55%2023: $16.0M$16.0M2023+29%2024: $21.3M$21.3M2024+33%2025: $20.2M$20.2M2025−5%
Net income789106$18.3M in 2025+16% since 2019
0$10.0M$20.0M$30.0M2019: $15.8M$15.8M20192020: $14.1M$14.1M2020−11%2021: $5.8M$5.8M2021−59%2022: $12.1M$12.1M2022+107%2023: $15.2M$15.2M2023+26%2024: $20.0M$20.0M2024+32%2025: $18.3M$18.3M2025−8%

Every line of the income statement as filed: the last 3 fiscal years, latest first.6

Period ending2025-12-312024-12-312023-12-31
Revenues, net$304.1M$291.6M$279.1M
Cost of revenues (excluding depreciation and amortization)$107.2M$97.9M$95.0M
Product development$51.0M$48.9M$45.5M
Sales and marketing$49.4M$47.2M$45.7M
General and administrative expenses$32.8M$35.1M$35.7M
Depreciation and amortization$43.5M$41.2M$41.1M
Total operating costs and expenses$283.8M$270.4M$263.0M
Operating income$20.2M$21.3M$16.0M
Interest income$3.3M$3.8M$2.4M
Other (expense) income, net-$358.0K-$318.0K$136.0K
Income before income tax provision$23.2M$24.8M$18.5M
Income tax provision$4.9M$4.8M$3.3M
Net income$18.3M$20.0M$15.2M
Basic (in dollars per share)$0.61$0.66$0.50
Diluted (in dollars per share)$0.61$0.66$0.50
Basic (in shares)30.0M shares30.4M shares30.6M shares
Diluted (in shares)30.1M shares30.5M shares30.7M shares
Dividends declared per share (in dollars per share)$0.12$0.11$0.10

Compare HEALTHSTREAM INC with another company

Corporate structure

HEALTHSTREAM INC sits at the top of its group. 6 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of HEALTHSTREAM INC

  • WJRJJ Ventures, LLC Filed SCHEDULE 13D on HEALTHSTREAM INC, latest Sep 21, 2026
  • DIMENSIONAL FUND ADVISORS LP Filed SCHEDULE 13G on HEALTHSTREAM INC, latest Jul 14, 2026 (3 filings since Feb 9, 2024)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on HEALTHSTREAM INC, latest Mar 27, 2026 (6 filings since Feb 10, 2022)
  • BlackRock Filed SCHEDULE 13G/A on HEALTHSTREAM INC, latest Apr 17, 2025 (5 filings since Jan 28, 2022)
  • HEALTHSTREAM INC Nashville, Tennessee, United States
    • HealthCare Research, LLC Subsidiary · Illinois, United States
    • HealthStream Information Solutions Company Subsidiary · Nova Scotia, Canada
    • HSTM Group Australia PTY Limited Subsidiary · Australia
    • HSTM Group New Zealand Subsidiary · New Zealand
    • MissionCare, LLC Subsidiary · Florida, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What HEALTHSTREAM INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$31.5M6 Dec 31, 2025$30.2M6 Dec 31, 2024+4.3%
Accumulated depreciation$20.9M6 Dec 31, 2025$19.5M6 Dec 31, 2024+7.1%
Property and equipment, net$10.7M6 Dec 31, 2025$10.7M6 Dec 31, 2024−0.7%
Operating-lease assets (leased space)$15.3M6 Dec 31, 2025$17.5M6 Dec 31, 2024−12.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$36.2M6 Dec 31, 2025$59.5M6 Dec 31, 2024−39.2%
Marketable securities, current$20.8M6 Dec 31, 2025$37.7M6 Dec 31, 2024−44.8%
Debt securities available for sale$20.8M6 Dec 31, 2025$37.7M6 Dec 31, 2024−44.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$217.5M6 Dec 31, 2025$191.2M6 Dec 31, 2024+13.8%
Intangible assets, net (excluding goodwill)$64.9M6 Dec 31, 2025$55.5M6 Dec 31, 2024+16.9%
Accumulated amortization$74.5M6 Dec 31, 2025$78.3M6 Dec 31, 2024−4.9%
Finite-lived intangibles, net$64.9M6 Dec 31, 2025$55.5M10 Dec 31, 2024+16.9%

Properties, in its own words

Our principal office is located in Nashville, Tennessee, which is primarily used to support our corporate functions. Our lease for approximately 92,000 square feet at this location will end in October 2031. During the first quarter of 2025, we entered into an agreement to sublease 66,000 square feet at this location, which sublease commenced in April 2025 and will expire in October 2031. As of December 31, 2025, we leased other facilities in Brentwood, Tennessee, San Diego, California, and St. Petersburg, Florida which all expire in 2026 and are not expected to be renewed.

Item 2 of the 10-K filed Feb 27, 2026.5

Leadership

Who has led HEALTHSTREAM INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Robert A. Frist Jr.2006–now

Chair

  1. Robert A. Frist Jr.2021–now

President

  1. Fred Perner2006
  2. J. Edward Pearson2018–2023

Chief financial officer

  1. Arthur E. Newman2006
  2. Susan Brownie2006–2007
  3. Gerard M. Hayden Jr.2008–2018
  4. Scott Alexander Roberts2019–now

Chief operating officer

  1. J. Edward Pearson2018–2023
2010201520202025
Board members and other officers (26)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerJeffrey D. Cunningham named Dec 30, 202547
  • DirectorCharles E. Beard, Jr. named Dec 30, 202547
  • DirectorDeborah Taylor Tate named Dec 30, 202547

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • HSTM Group Australia PTY Limited Australia4
  • HSTM Group New Zealand New Zealand4
  • HealthCare Research, LLC Illinois4
  • HealthStream Information Solutions Company Nova Scotia, Canada4
  • MissionCare, LLC Florida4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Sep 23, 20268-K Executive or director change48
  2. Sep 15, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure49
  3. Sep 14, 20268-K Entered a material agreement; New debt or obligation50
  4. Aug 3, 20268-K Results of operations; Regulation FD disclosure; Other events51
  5. Jul 29, 20268-K Other events52
  6. May 29, 20268-K Shareholder vote53
  7. May 8, 20268-K Executive or director change54
  8. May 4, 20268-K Results of operations; Regulation FD disclosure; Other events55
  9. Mar 13, 20268-K Entered a material agreement; Other events56
  10. Feb 23, 20268-K Results of operations; Regulation FD disclosure; Other events57
  11. Dec 15, 20258-K Other events58
  12. Dec 9, 20258-K Other events59
  13. Feb 21, 2006New chief executive Robert A. Frist Jr. becomes CEO14

Calendar

Coming up

  1. Nov 2, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.20 a share, on Nov 3, 2025.60

When it reported results

  1. Aug 3, 2026Reported quarterly or annual results51
  2. May 4, 2026Reported quarterly or annual results55
  3. Feb 23, 2026Reported quarterly or annual results57
  4. Nov 3, 2025Reported quarterly or annual results61
  5. Aug 4, 2025Reported quarterly or annual results62
  6. May 5, 2025Reported quarterly or annual results63
  7. Feb 24, 2025Reported quarterly or annual results64
  8. Oct 21, 2024Reported quarterly or annual results65

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

523 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 401 insider forms, 15 large holders, 1 private raises, 32 other. The latest 20:

  1. Sep 29, 20264 EDGAR
  2. Sep 29, 20264 EDGAR
  3. Sep 29, 20264 EDGAR
  4. Sep 29, 20264 EDGAR
  5. Sep 29, 20264 EDGAR
  6. Sep 29, 20264 EDGAR
  7. Sep 29, 20264 EDGAR
  8. Sep 29, 20264 EDGAR
  9. Sep 23, 20268-K EDGAR
  10. Sep 22, 20264 EDGAR
  11. Sep 22, 20264 EDGAR
  12. Sep 22, 20264 EDGAR
  13. Sep 22, 20264 EDGAR
  14. Sep 22, 20264 EDGAR
  15. Sep 22, 20264 EDGAR
  16. Sep 22, 20264 EDGAR
  17. Sep 22, 20264 EDGAR
  18. Sep 21, 2026SCHEDULE 13D EDGAR
  19. Sep 15, 20264 EDGAR
  20. Sep 15, 20268-K EDGAR

The 523 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

22 open-market trades by officers, directors and large owners since October 2021: 2 buys and 20 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 14, 2026FRIST ROBERT A JRCEO and ChairmanSale144,068$29.50$4.3MForm 4
Jul 6, 2026REBROVICK LINDADirectorSale6,000$29.00$174.0KForm 4
Jun 1, 2026REBROVICK LINDADirectorSale2,000$25.00$50.0KForm 4
May 28, 2026REBROVICK LINDADirectorSale2,000$25.00$50.0KForm 4
May 20, 2026O'Hara Kevin PExecutive Vice PresidentSale3,000$24.08$72.2KForm 4
Dec 10, 2025Cunningham JeffChief Technology OfficerSale2,100$24.09$50.6KForm 4
Dec 8, 2025O'Hara Kevin PExecutive Vice PresidentSale2,000$24.26$48.5KForm 4
Nov 26, 2025Taylor Tate DeborahDirectorSale1,580$25.46$40.2KForm 4
Aug 27, 2025O'Hara Kevin PExecutive Vice PresidentSale2,000$27.97$55.9KForm 4
Feb 27, 2025Fenstermacher ScottSenior Vice PresidentSale2,000$33.15$66.3KForm 4
Aug 29, 2024Taylor Tate DeborahDirectorSale1,400$28.53$39.9KForm 4
Aug 26, 2024Fenstermacher ScottSenior Vice PresidentSale1,000$28.99$29.0KForm 4
Aug 7, 2024O'Hara Kevin PExecutive Vice PresidentSale3,000$28.03$84.1KForm 4
May 1, 2024Fenstermacher ScottSenior Vice PresidentSale1,000$26.19$26.2KForm 4
Feb 26, 2024Sousa MichaelExecutive Vice PresidentSale15,000$27.25$408.8KForm 4
Feb 22, 2024Fenstermacher ScottSenior Vice PresidentSale1,000$26.59$26.6KForm 4
Feb 22, 2024Coady Trisha LExecutive Vice PresidentSale7,000$26.34$184.4KForm 4
Apr 27, 2023PEARSON J EDWARDPresident and COOSale15,150$24.96$378.1KForm 4
Feb 24, 2023Taylor Tate DeborahDirectorSale3,374$25.26$85.2KForm 4
Jul 29, 2022MCLAREN JEFFREY LDirectorSale5,000$24.17$120.8KForm 4

All 22 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Michael M. Collier50$381.9K$1.1M70
2025Kevin P. O'Hara57$6$1.1M70
2025Trisha L. Coady50$371.1K$1.0M70
2025Scott A. Roberts49$344.0K$868.3K70
2025Robert A. FristJr.59$400.5K$868.0K70
2024Executive VicePresident,$359.3K$848.8K70
2024Chief Executive Officer$387.7K$702.1K70
2024Senior VicePresident and$330.0K$691.9K70
2023Corporate StrategyDevelopment, and Operations$343.3K$834.2K70
2023Chief Executive Officer$380.0K$727.1K70
2023Workforce Development Solutions$326.7K$706.0K70
2023Chief Financial Officer$313.3K$685.9K70

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$4.0M 2025–2025
Money received by yearMoney received by year, 2025–2025: $4.0M in all. Private raises (Form D) $4.0M.$0$1M$2M$3M$4M2025 · Private raises (Form D): $4.0M2025
Figures by year
YearPrivate raises (Form D)Total
2025$4.0M$4.0M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Dec 15, 2025Raised $4 million in a private offering of equity47 Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.4,080,144$111.2M0.0%+228,215
Dimensional Fund Advisors LP1,557,981$42.5M0.0%+101,938
Copeland Capital Management, LLC1,248,384$34.0M0.7%−28,355
First Eagle Investment Management, LLC1,183,796$32.3M0.0%+758,098
Vanguard Capital Management LLC1,045,298$28.5M0.0%−2,629
State Street Corp1,004,170$27.4M0.0%+8,613
Vanguard Portfolio Management LLC880,543$24.0M0.0%−41,303
Two Sigma Investments, LP805,584$22.0M0.0%−38,836
Geode Capital Management, LLC779,219$21.2M0.0%+64,472
Goldman Sachs Group Inc665,917$18.1M0.0%+391,459
Jpmorgan Chase & Co635,565$17.2M0.0%+181,827
Arrowstreet Capital, Limited Partnership433,651$11.8M0.0%+55,706
Renaissance Technologies LLC423,000$11.5M0.0%−54,848
Morgan Stanley382,954$10.4M0.0%+13,968
Northern Trust Corp379,711$10.3M0.0%+18,034
Creative Planning285,852$7.8M0.0%+67,666
Lazard Asset Management LLC240,950$6.6M0.0%+83,742
Aqr Capital Management LLC240,232$6.5M0.0%+181,390
Charles Schwab Investment Management Inc237,710$6.5M0.0%−27,934
Bank of New York Mellon Corp227,493$6.2M0.0%+3,856
Kennedy Capital Management LLC191,504$5.2M0.1%−3,737
Nuveen, LLC189,904$5.2M0.0%+138,153
Envestnet Asset Management Inc189,539$5.2M0.0%−10,092
Fmr LLC166,812$4.5M0.0%−8,338
Sei Investments Co157,794$4.3M0.0%+11,394

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How HEALTHSTREAM INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHEALTHSTREAM INC1
  • CIK0001095565
  • Employer ID (EIN)62-14435555
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
  • Incorporated inTennessee5
  • Fiscal year endsDecember 311
  • Industry code (SIC)7370 Services-Computer Programming, Data Processing, Etc.1
  • SEC reviewing officeOffice of Technology, Division of Corporation Finance1
  • Business address500 11Th Avenue North, Suite 850, Nashville, TN1
  • Phone61530131001
  • Shares outstanding29,239,955 as of Aug 3, 202612
  • Public float$654.7M as of Jun 30, 20255
  • AuditorErnst & Young LLP, Nashville, Tennessee PCAOB ID 42; it also attests to the company’s internal control over financial reporting5
  • On EDGAR sinceOct 13, 19991
  • Filings1,641 in all: 4 (1,063), 8-K (210), 10-Q (80), SC 13G/A (57), DEF 14A (26), 10-K (25), 3 (22), 4/A (17)1
    All 37 form types

    DEFA14A (15), SC 13G (14), UPLOAD (13), CORRESP (11), ARS (10), 144 (9), 11-K (8), 5 (7), 8-K/A (7), EFFECT (6), S-1/A (5), SCHEDULE 13G/A (5), 424B5 (4), S-8 (4), POS AM (3), S-3 (3), 10-Q/A (2), D (2), S-3ASR (2), S-8 POS (2), 10-K/A (1), 10-K405 (1), 144/A (1), 424B1 (1), 8-A12G (1), REGDEX/A (1), S-1 (1), SCHEDULE 13D (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Feb 27, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Apr 10, 2026
    Latest 8-K (8-K) Sep 23, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock (Par Value $0.00)HSTMNasdaq

From the cover page of the 10-K filed Feb 27, 2026 (Section 12(b) of the Exchange Act).5

Risk factors and legal proceedings

The risks HEALTHSTREAM INC names in Item 1A of its 10-K filed Feb 27, 2026: 38 risks under these headings, as written.5

  • Risks Related to Our Business Model
  • We have been adversely impacted, and may continue to be adversely impacted, by unfavorable conditions and uncertainty in the healthcare industry and the U.S. economy more generally.
  • We may be unable to effectively execute our business strategy, which could have an adverse effect on our business and competitive position in the industry.
  • The development and use of AI or the failure to adequately or appropriately develop and use AI, including generative AI and agentic AI, may result in reputational harm, liability, and adverse financial results, and could impact our value proposition.
  • A deterioration of public health conditions associated with a future pandemic, epidemic, or public health event, or a future catastrophic event, could adversely affect our business and financial results.
  • We may be unable to effectively identify, complete, or integrate the operations of acquisitions, joint ventures, collaborative arrangements, or other strategic investments, which would inhibit our ability to execute upon our growth strategy.
  • We are subject to risks associated with our equity investments, including partial or complete loss of invested capital, and significant changes in the fair value of these investments could adversely impact our financial results.
  • Our financial performance may be difficult to predict as the result of lengthy and widely varying sales cycles and other factors.
  • We may not be able to maintain our competitive position against current and potential competitors, especially those with significantly greater financial, technical, marketing, or other resources.
  • Expanding our business model such that third parties may pay network connection fees in exchange for the ability to deliver their products through our technology platform and have them featured as part of our ecosystem may result in unpredictability and/or harm to the operational and financial performance of our business.
  • The failure to maintain and strengthen our relationships with ecosystem partners or significant changes in the terms of the agreements we have with ecosystem partners may have an adverse impact on our ability to successfully market, sell, and deliver certain product and service offerings.
  • We may not be able to develop new products and services or enhancements to our existing products and services, or be able to achieve widespread acceptance of new products, services, or features, or keep pace with technological developments.
The other 27 risks
  • We may be unable to continue to license our third-party software, on which a portion of our product and service offerings rely, or we may experience errors in this software, which could adversely impact our business.
  • Financial Risks
  • A significant portion of our revenue is generated from a relatively small number of customers.
  • A significant portion of our business is subject to renewal. Therefore, renewals have a significant impact on our revenue and operating results.
  • Failure to adequately optimize our direct sales infrastructure will impede our growth.
  • We may be unable to accurately predict the timing of revenue recognition from sales activity as it is often dependent on achieving certain events or performance milestones, and this inability could impact our operating results.
  • Because we recognize revenue from subscriptions for our products and services over the term of the subscription period, downturns or upturns in new sales and renewals may not be immediately reflected in our operating results.
  • We may not be able to meet our strategic business objectives unless we obtain additional financing, which may not be available to us on favorable terms or at all.
  • Goodwill, identifiable intangible assets, long-lived assets, and strategic investments recorded on our balance sheet may be subject to impairment losses that could reduce our reported assets and earnings.
  • We may be affected by public policy developments and other changes and uncertainty in the healthcare industry that impact us and our clients.
  • We may discover weaknesses in our internal controls over financial reporting, which may adversely affect investor confidence in the accuracy and completeness of our financial reports and consequently the market price of our securities.
  • Risks Related to Operations
  • Our operating margins could be affected if our ongoing refinement to pricing models for our products and services is not accepted by our customers and the market.
  • We may be unable to adequately develop our systems, processes, and support in a manner that will enable us to meet the demand for our products and services.
  • We operate in a challenging market for talent and may fail to attract and retain qualified personnel, including key management personnel.
  • We may not be able to implement or upgrade our technology infrastructure and initiatives to effectively meet demand for our services or our operational needs.
  • Our network infrastructure and computer systems and software may fail.
  • A data breach or cybersecurity incident could result in a loss of confidential data, give rise to remediation and other expenses, expose us to liability, subject us to litigation and governmental inquiries and actions, damage our reputation, and otherwise adversely impact our financial results and business.
  • We may experience errors or omissions in our software products or processes, including those that deliver credentialing, privileging, and payer enrollment services for our healthcare customers and those that administer and report on healthcare facility performance, and these errors could result in action taken against us that could harm our business.
  • Risks Related to Government Regulation, Content, and Intellectual Property
  • Government regulation may subject us to investigation, litigation, or liability or require us to change the way we do business.
  • Any reduction or change in the regulation of continuing education and training in the healthcare industry may adversely affect our business.
  • We may be liable to third parties for content that is sold or made available by us.
  • Protection of certain intellectual property may be difficult and costly, and our inability to protect our intellectual property could reduce the value of our products and services or reduce our competitive advantage.
  • We may be liable for infringing the intellectual property rights of others.
  • We use open source software in our products, which could subject us to litigation or other actions.
  • Our sources of data might restrict our use of or refuse to license data, which could adversely impact our ability to provide certain products or services.
  • Risks Related to International Operations
  • We face risks arising from our international operations.
  • Risks Related to Ownership of Our Common Stock
  • It may be difficult for a third party to acquire our company.
  • There is no assurance that we will not discontinue or reduce the amount of our current quarterly dividend.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
    SEC EDGAROther events
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
    SEC EDGAROther events
  59. 59
    SEC EDGAROther events
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70